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INTRODUCTION {#sec1-1}
============

Influenza A, influenza B, respiratory syncytial virus (RSV), parainfluenza virus (PIV), and adenovirus (AdV) represent the most common viruses causing acute respiratory diseases resulting in significant morbidity and mortality. Conventional culture methods used to isolate respiratory viruses are based on tissue culture methods utilizing a panel of cell lines that include MDCK (Madin--Darby canine kidney), LLC‐MK2 (Rhesus monkey kidney), HEp‐2 (laryngeal cancer), A549 (human lung carcinoma), and RD (Rhabdomyosarcoma). Maintenance of different cell lines is complicated, cumbersome, requires long turnaround times, and is expensive. The RhMK (primary rhesus monkey kidney) cell line has been used for isolation of various respiratory viruses. However, the availability of primary cells, varying susceptibility to infection with different respiratory viruses, the potential of harboring endogenous foamy virus, and high costs limit the use of this cell line in diagnostic virology laboratories. Commercial R‐Mix (Mix cells with A549 and Mint Lung) and super E‐Mix (genetically engineered BGMK and Caco‐2 cells) have replaced the conventional cell line panel for the isolation of respiratory viruses \[Lee et al., [1992](#bib10){ref-type="ref"}; Buck et al., [2002](#bib2){ref-type="ref"}; Weinberg et al., [2004](#bib18){ref-type="ref"}\]. Caco‐2 cells have also been used to isolate enteroviruses, enteric viruses, and influenza viruses \[Reigel, [1985](#bib15){ref-type="ref"}; Pintó et al., [1994](#bib14){ref-type="ref"}; Yoshino et al., [1998](#bib20){ref-type="ref"}; Chiapponi et al., [2010](#bib5){ref-type="ref"}; Jahangir et al., [2010](#bib7){ref-type="ref"}\]. Several studies have also showed that Caco‐2 cells have the ability to propagate coronaviruses NL63 and SARS from culture isolates \[Spiegel and Weber, [2006](#bib17){ref-type="ref"}; Müller et al., [2010](#bib12){ref-type="ref"}\]. However, the efficacy of Caco‐2 cells in isolating common respiratory viruses directly from clinical samples remains unknown. In this study, the efficacy of isolating respiratory viruses from Caco‐2 cells was compared to isolation from the conventional cell line panel.

MATERIALS AND METHODS {#sec1-2}
=====================

Nasopharyngeal Aspirate Samples {#sec2-1}
-------------------------------

Nasopharyngeal aspirates were sent to the virology laboratory for routine direct immunofluorescence antigen testing to diagnose infections caused by respiratory viral diseases and residual samples were used for this study. One hundred eighty‐nine nasopharyngeal aspirate specimens positive by direct immunofluorescence antigen confirmation were evaluated. The specimens were collected from 94 males and 95 females with a mean age of 30.4 years (range 1 month to 102 years of age). The positive direct immunofluorescence antigen testing identified 27 RSV, 38 influenza A, 32 influenza B, 20 PIV‐1, 11 PIV‐2, 30 PIV‐3, 18 PIV‐4, and 13 AdV isolates. This study was approved by the Institutional Review Board of the University of Hong Kong Hospital Authority, Hong Kong, West Cluster.

Viral Cultures {#sec2-2}
--------------

MDCK, LLC‐MK2, HEp‐2, A549, and Caco‐2 (ATCC HTB 37) cell monolayers grown in culture tubes were inoculated with 200 µl of each Nasopharyngeal aspirate sample and incubated at 35°C for 1 hr \[Chan et al., [2008](#bib4){ref-type="ref"}; Li et al., [2009](#bib11){ref-type="ref"}\]. MDCK and LLC‐MK2 cells were fed with 1 ml of serum‐free minimum essential medium (MEM) (GibcoBRL, Grand Island, NY) containing TPCK (tosylsulfonyl phenylalanyl chloromethyl ketone)‐treated trypsin (2 µg/ml) (Sigma, St. Louis, MO), and antibiotics (Garamycin, 0.02 mg/ml, Schering‐Plough Corporation, Heist‐op‐den‐Berg, Belgium; penicillin--streptomycin, 100 units/ml, GibcoBRL; nystatin, 20 units/ml, Sigma). Caco‐2; HEp‐2, and A549 cells were fed with 1 ml of MEM supplemented with 1% fetal calf serum (GibcoBRL) and antibiotics. Culture tubes were incubated using a roller apparatus at a speed of 12--15 revolutions per hour at 35°C. The cultures were then examined for virus‐induced cytopathic effect (CPE) daily for up to 10 days. At the end of the incubation period, or when CPE was detected, a cell scraper was used to collect cells that were mounted subsequently on Teflon‐coated slides, fixed, and immunostained with IMAGEN™ respiratory screen and typing reagents (Oxoid, Hampshire, UK) specific for viral antigens.

Direct Immunofluorescence Antigen Testing {#sec2-3}
-----------------------------------------

Direct immunofluorescence antigen testing was carried out on nasopharyngeal aspirate specimens or culture‐infected cells as described previously \[Chan et al., [2002](#bib3){ref-type="ref"}\]. Briefly, nasopharyngeal aspirate or infected cells were centrifuged, and the cell pellet washed in phosphate‐buffered saline (PBS). The cell pellet was then spotted on 6‐mm teflon‐coated slide wells, air dried, and fixed in ice‐cold acetone for 10 min. Smears were stained with IMAGEN™ respiratory screen and typing reagents for influenza virus type A and B, RSV, PIV screen and typing, AdV (Oxoid), and PIV‐4 (Millipore, Temecula, CA) and viewed at a magnification of 400× under epi‐fluorescence illumination using the fluorescein isothiocyanate (FITC) filter of a fluorescence microscope (Euroimmun, Luebeck, Germany).

Nucleic Acid Extraction and PCR for Respiratory Viruses {#sec2-4}
-------------------------------------------------------

Nucleic acids were extracted using the NucliSens EasyMAG automatic robotic platform (bioMerieux, Marcy‐l\'Etoile, France) according to the manufacturer\'s instructions. Briefly, 250 µl of a nasopharyngeal aspirate sample was added to 2 ml of lysis buffer and the mixture incubated for 10 min at room temperature. Total nucleic acid was recovered in 55 µl of elution buffer after magnetic separation \[Chan et al., [2008](#bib4){ref-type="ref"}\]. PIV were identified by a set of multiplex primers used to amplify the hemagglutinin‐neuraminidase gene of PIV‐1, ‐2, and ‐3 or the phosphoprotein gene of PIV‐4 \[Aguilar et al., [2000](#bib1){ref-type="ref"}\].

Data Analysis {#sec2-5}
-------------

Sensitivity of detection for a particular cell line was defined as the number of positive cultures divided by the total number of direct immunofluorescence antigen test positive samples. Chi‐square analysis was used to compare the sensitivity between different cell lines. A *P*‐value of \<0.05 was considered as statistically significant.

RESULTS {#sec1-3}
=======

One hundred eighty‐five nasopharyngeal aspirate samples were direct immunofluorescence antigen positive for eight common respiratory viruses subsequently cultured in five cell lines: Caco‐2, A549, HEp‐2, LLC‐MK2, and MDCK (Table [I](#tbl1){ref-type="table"}). Overall the sensitivity of Caco‐2 cells \[84% (159/189)\] for recovery of these respiratory viruses was higher than the sensitivity of the cell panel \[78% (147/189)\], however, this difference was not statistically significant (*P* = 0.150). When the sensitivity was compared to individual cell lines in the panel (MDCK \[38%\], HEp‐2 \[21%\], LLC‐MK2 \[27%\], and A549 \[37%\]) detection differences were statistically significant (*P* = \< 0.000001).

###### 

Comparison of the Caco‐2 Cell Line With Conventional Cell Lines Used in the Recovery of Respiratory Viruses From Nasopharyngeal Aspirate

  Direct immunofluorescence antigen test positive   Number of nasopharyngeal aspirates   Caco‐2 number positive (%)   A549 number positive (%)   HEp‐2 number positive (%)   LLC‐MK2 number positive (%)   MDCK number positive (%)
  ------------------------------------------------- ------------------------------------ ---------------------------- -------------------------- --------------------------- ----------------------------- --------------------------
  RSV                                               27                                   20 (74%)                     14 (52%)                   22 (81%)                    5 (19%)                       0%
  Flu A                                             38                                   35 (92%)                     4 (11%)                    0%                          3 (8%)                        36 (95%)
  Flu B                                             32                                   25 (78%)                     7 (22%)                    0%                          3 (9%)                        31 (97%)
  PIV‐1                                             20                                   16 (80%)                     20 (100%)                  0%                          20 (100%)                     3 (15%)
  PIV‐2                                             11                                   11 (100%)                    5 (45%)                    1 (9%)                      7 (64%)                       1(9%)
  PIV‐3                                             30                                   22 (73%)                     6 (20%)                    4 (13%)                     11 (37%)                      0%
  PIV‐4                                             18                                   18 (100%)                    1 (6%)                     1 (6%)                      2 (11%)                       1 (6%)
  AdV                                               13                                   12 (92%)                     13 (100%)                  12 (92%)                    0%                            0%
  Total                                             189                                  159 (84%)                    70 (37%)                   40 (21%)                    51 (27%)                      72 (38%)

RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.
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CPE was observed for all virus‐infected Caco‐2 cells except PIV between days 3 and 8 (Fig. [1](#fig1){ref-type="fig"}). CPE was observed for RSV, PIV‐1, ‐2, and AdV but not influenza virus‐infected A549 cells between days 3 and 6. CPE was only observed for RSV, PIV‐4, and AdV infected HEp‐2 cells between days 2 and 5. CPE was not discernable in virus‐infected LLC‐MK2 cells except for RSV and PIV‐1 that induced CPE between days 3 and 7. Only influenza virus was able to induce CPE in MDCK cells between days 2 and 5. All virus‐infected cells developing or not developing CPE were also stained with a panel of fluorescein labeled monoclonal antibodies to confirm infection as described in [Materials and Methods](#sec1-2){ref-type="sec"} Section (Fig. [2](#fig2){ref-type="fig"}).

![CPE in Caco‐2 cells following infections with (**A**) RSV, (**B**) AdV, (**C**) Flu A, (**D**) Flu B, and (**E**) a virus negative nasopharyngeal aspirate.](JMV-85-874-g001){#fig1}

![Antigen expression in Caco2 cells identified by direct immunofluorescence staining using a panel of monoclonal antibodies specific for respiratory viruses. **A**: RSV, (**B**) AdV, (**C**) Flu A, (**D**) Flu B, (**E**) PIV‐1, (**F**) PIV‐2, (**G**) PIV‐3, (**H**) PIV‐4, and (**I**) a virus negative nasopharyngeal aspirate.](JMV-85-874-g002){#fig2}

The sensitivities of different combinations of conventional panel cell lines (LLC‐MK2, A549, MDCK, and HEp‐2) with Caco‐2 cells were 88%, 88%, 89%, and 87%, respectively (Table [III](#tbl3){ref-type="table"}). Of the 42 cultures that were negative using the conventional cell culture panel, 36 were positive when cultured with Caco‐2 cells. Conversely, 30 Caco‐2 cultures were negative and 24 were conventional panel positive (Table [II](#tbl2){ref-type="table"}). There were 6 PIV‐3 direct immunofluorescence antigen test positive specimens with negative viral cultures that were confirmed positive by RT‐PCR.

###### 

Evaluation of Negative Cultures Following Culture With Panel Cells Compared to Culture With Caco‐2 Cells Resulting in Positive Viral Propagation and Vice Versa

  Virus type   Panel cells negative   Caco‐2 cells positive   Caco‐2 cells negative   Panel cells positive
  ------------ ---------------------- ----------------------- ----------------------- ----------------------
  RSV          2                      2                       7                       7
  Flu A        2                      2                       3                       3
  Flu B        1                      1                       7                       7
  PIV‐1        0                      0                       4                       4
  PIV‐2        4                      4                       0                       0
  PIV‐3        17                     11                      8                       2
  PIV‐4        16                     16                      0                       0
  AdV          0                      0                       1                       1
  Total        42                     36                      30                      24

RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.
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DISCUSSION {#sec1-4}
==========

In this study, Caco‐2 cells \[84% (159/189)\] were shown to be more efficient for propagating the most common respiratory viruses associated with clinical NPA samples compared to the conventional cell panel comprised of the MDCK \[(38% (72/189)\], HEp‐2 \[21% (40/189)\], A549 \[38% (70/189)\], and LLC‐MK2 \[(27% (51/189)\] cell lines used for virus propagation or positive by any cell line in the panel \[78% (147/189)\]. Caco‐2 cells were the most efficient cell line for isolating PIV‐2--4, and HEp2, MDCK, LLC‐MK2, and A549 were the most efficient cell lines for recovering RSV, influenza A and B, PIV‐1, and adenovirus, respectively (Table [I](#tbl1){ref-type="table"}). One of the major advantages of using Caco‐2 cells was that viruses were recovered from this cell line that could not be cultured using cell lines comprising the conventional cell panel (Table [II](#tbl2){ref-type="table"}). However, Caco‐2 cells required a 2--5 day‐longer incubation time for virus recovery compared to the other cell lines. The sensitivity was increased from 84% to 87--89% if Caco‐2 were used with any one of the cell lines comprising the conventional panel (Table [III](#tbl3){ref-type="table"}). In order to maximize the sensitivity and decrease costs, combining Caco‐2 and MDCK cells can be used during influenza seasons to isolate the maximum number of influenza viruses. Combinations of Caco‐2 with LLC‐MK2 or A549 cells can be used to culture other viruses at other times of the year.

###### 

Different Caco‐2 Combinations With Panel Cell Lines Used in the Recovery of Respiratory Viruses

  Cell lines         RSV (n = 27)   Flu A (n = 38)   Flu B (n = 32)   PIV‐1 (n = 20)   PIV‐2 (n = 11)   PIV‐3 (n = 30)   PIV‐4 (n = 15)   AdV (n = 13)   Total culture positive   Percentage positive (%)
  ------------------ -------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- -------------- ------------------------ -------------------------
  Caco‐2             20             35               25               16               11               22               18               12             159                      84
  Caco‐2 + A549      22             35               25               20               11               23               18               13             167                      88
  Caco‐2 + MDCK      20             38               32               16               11               22               18               12             169                      89
  Caco‐2 + HEp‐2     25             35               25               16               11               22               18               13             165                      87
  Caco‐2 + LLC‐MK2   23             35               25               20               11               23               18               12             167                      88

RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.
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Furthermore, the Caco‐2 cell line does not require the addition of trypsin to isolate influenza viruses because they already cleave viral HA0 into the HA1 and HA2 subunits \[Yoshino et al., [1998](#bib20){ref-type="ref"}; Chiapponi et al., [2010](#bib5){ref-type="ref"}\] and are susceptible to CPE \[Zhirnov and Klenk, [2003](#bib21){ref-type="ref"}\]. PIV‐4 was reported to be quite difficult to isolate in cell culture \[Laurichesse et al., [1999](#bib9){ref-type="ref"}; Lau et al., [2005](#bib8){ref-type="ref"}\]. In this study, Caco‐2 cell cultures efficiently supported the replication of PIV, particularly PIV‐4 (Tables [I](#tbl1){ref-type="table"} and [II](#tbl2){ref-type="table"}). Human PIVs have often been associated with upper respiratory tract infections and other more severe disease, especially in immunocompromised patients \[Woo et al., [2000](#bib19){ref-type="ref"}; Cortez et al., [2001](#bib6){ref-type="ref"}\]. PIV‐4 was associated with an outbreak involving 38 institutionalized children and three staff members \[Lau et al., [2005](#bib8){ref-type="ref"}\] and also played an important role in causing acute lower respiratory tract infections in children \[Ren et al., [2011](#bib16){ref-type="ref"}\].

Although antigen detection using immunofluorescence and nucleic acid detection by RT‐PCR are widely used in clinical diagnostic laboratories, it is important to maintain viral cultures since viral isolates are important for carrying out detailed molecular studies that require sufficient amounts of viral nucleic acid. This is especially important during the first isolation and characterization of new viruses, such as the SARS coronavirus \[Peiris et al., [2003](#bib13){ref-type="ref"}\]. A simple culture work flow will facilitate diagnostic virology services since clinical laboratories are the first to process these specimens and would therefore have the highest chance of isolating respective virus since sample storage may reduce viral culture yields if processed at a later time.
